Skip to main content

SUMO1 Antibody (5G3)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26296

Recombinant monoclonal antibody expressed in HEK293F cells
Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-26296-100ul
NBP3-26296-50ul

Key Product Details

Species Reactivity

Human

Applications

ELISA, Flow Cytometry, Immunohistochemistry, Immunoprecipitation

Label

Unconjugated

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # 5G3

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

A synthesized peptide derived from Human SUMO1 [UniProt P63165]

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for SUMO1 Antibody (5G3)

SUMO1 Antibody (5G3)

Immunoprecipitation: SUMO1 Antibody (5G3) [NBP3-26296] -

Immunoprecipitation: SUMO1 Antibody (5G3) [NBP3-26296] - Immunoprecipitating SUMO1 in 293T whole cell lysate.
Lane 1: Rabbit control IgG instead of NBP3-26296 in 293T whole cell lysate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000).
Lane 2: NBP3-26296 (3ug) + 293T whole cell lysate (500ug).
Lane 3: 293T whole cell lysate (20ug).
SUMO1 Antibody (5G3)

Immunohistochemistry: SUMO1 Antibody (5G3) [NBP3-26296] -

Immunohistochemistry: SUMO1 Antibody (5G3) [NBP3-26296] - Image of SUMO1 Antibody (5G3) diluted at 1:92.5 and staining in paraffin-embedded human adrenal gland tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
SUMO1 Antibody (5G3)

Immunohistochemistry: SUMO1 Antibody (5G3) [NBP3-26296] -

Immunohistochemistry: SUMO1 Antibody (5G3) [NBP3-26296] - Image of SUMO1 Antibody (5G3) diluted at 1:92.5 and staining in paraffin-embedded human adrenal gland tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.

Applications for SUMO1 Antibody (5G3)

Application
Recommended Usage

Immunohistochemistry

1:50-1:200

Immunoprecipitation

1:200-1:1000

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, pH 7.4, 150mM NaCl and 50% glycerol

Preservative

0.02% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20 to -70C. Avoid freeze-thaw cycles.

Background: SUMO1

Sumo 1 is a ubiquitin-like protein which binds to a wide range of target proteins. Does not seem to be involved in protein degradation and may function as an antagonist of ubiquitin in the degradation process. Plays a role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Involved in targeting RANGAP1 to the nuclear pore complex protein RANBP2. SUMO 1 is also known to form a complex with RanGAP1.

Long Name

Small Ubiquitin-like Modifier 1

Alternate Names

PIC1, Sentrin, SMT3C, SMT3H3, UBL1

Gene Symbol

SUMO1

Additional SUMO1 Products

Product Documents for SUMO1 Antibody (5G3)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SUMO1 Antibody (5G3)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...